Cleveland Clinic is launching the Quantum Innovation Catalyzer Program, a chance for start-up companies in healthcare technology and life sciences to gain experience with quantum computing and apply it to their research and development work under expert guidance.Read More
Cleveland Clinic researchers have pinpointed the transcription factor that regulates the differentiation of CD4+ helper cells into a subset that has anti-tumor effects.
Enhancing synaptic pruning to reduce the number of faulty or immature neuronal connections may one day help restore some cognitive abilities in patients with autism spectrum disorders.
A research team led by noted Cleveland Clinic physician-researcher Nima Sharifi, MD, is honing in on what makes certain men more susceptible to prostate cancer that is likely to progress from hormone-sensitive to castration-resistant.
Addressing the challenge of opioid tolerance and overdose, Cleveland Clinic research finds new treatment option may improve opioid therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Molecular-level research reveals that a simple change in one of more than 2,600 amino acids in the protein filamin is responsible for the devastating disease known as frontometaphyseal dysplasia.
If the reason we get fat is in our genes, inhibiting this protein might possibly prevent obesity and the diseases associated with it.